Erica Mayer
@elmayermd
Followers
4K
Following
7K
Media
238
Statuses
1K
Institute Physician, Susan F. Smith Breast Oncology Center, @danafarber. Tweets are my own not medical advice.
Joined September 2016
RT @GuiNaderMarta: Inavolisib triplet approval marks real progress for pts w/ PIK3CA-mut HR+ mBC. With progress come new questions—on pt se….
0
25
0
RT @DanaFarber: .@elmayermd, MPH, presents a poster on RYZ101 (²²⁵Ac-DOTATATE) in ER+/HER2 - advanced #breastcancer after prior therapy - e….
0
3
0
RT @DFCI_BreastOnc: Dr. Erica Mayer (@elmayermd) presented results from the #TRADEstudy at #ASCO25, which showed that an initial dose escal….
0
14
0
RT @DFCI_BreastOnc: #ASCO25 #MetastaticBreastCancer Poster Session: Assessing the impact of #ScalpCooling in patients receiving #Trastuzuma….
0
12
0
RT @PTarantinoMD: With ASCO25 wrapping up, I wanted to acknowledge the impact of a person that— between leading @DFCI_BreastOnc, caring for….
0
29
0
RT @nlinmd: Congrats to Dr Ian Krop @YaleCancer on the Bonadonna Award, honoring his practice-changing work in breast cancer! . Wonderful i….
0
12
0
RT @DFCI_BreastOnc: Check out the #ASCO25 Central Nervous System Tumors poster session on Saturday for a presentation by Guilherme Nader-Ma….
0
6
0
RT @GuiNaderMarta: Join us at #ASCO25 tomorrow to discuss the efficacy of immune checkpoint inhibitors in patients with CNS metastases from….
0
11
0
RT @stolaney1: SERENA-6: ctDNA guided approach to switching from AI to camizestrant upon development of ESR1m in combo with cdk4/6i demonst….
0
44
0
RT @MichaelGnant: Important publication on the #pallas trial! Thank you @angiedemichele @elmayermd for a great global collaboration. @abcsg….
0
8
0
RT @OncLive: @elmayermd of @DanaFarber shares insight on responses with preoperative niraparib plus dostarlimab in patients with BRCA-mutan….
0
2
0
RT @hoperugo: Wow. I am so grateful for our BC community for supporting our good friend and colleague @dradityabardia and his family duri….
0
15
0
RT @DFCI_BreastOnc: Congratulations to Adrienne Waks, MD, (@adawaksmd), Associate Director of Clinical Research @DFCI_BreastOnc, on this pr….
0
7
0
RT @DFCI_BreastOnc: Check out this recent commentary from Drs. Megan Tesch (@MeganTesch), Douglas Drachman (@DougDrachmanMD) and Erica Maye….
0
9
0
RT @DFCI_BreastOnc: The new ZAP-IT study is evaluating the safety and effectiveness of #Azenosertib (ZN-c3) in combination with carboplatin….
0
5
0
RT @GuiNaderMarta: Honored to share our article in the @NEJM Breast Cancer Update, discussing two perspectives on anthracycline use in brea….
0
37
0
RT @DFCI_BreastOnc: The CDK4/6 Inhibitor Dosing Knowledge (#CDK) Study investigating personalized dosing strategies for CDK4/6 inhibitors i….
0
8
0
RT @ASCO: Exciting News! 🚨 Our @PCORI-funded CDK Study has officially enrolled its 1st patient at @IronwoodCancer, a BIG step forward in im….
0
5
0
RT @FilipaLynce: So proud of Dr. Caroline Block, recipient of the Arthur Skarin Award and Dr. Geoff Shapiro @GShapiroMDPhD, recipient of th….
0
8
0
RT @FilipaLynce: @stolaney1 @DFCI_BreastOnc @DrHBurstein @PTarantinoMD @IlanaSchlam @antgiorda @elmayermd @adawaksmd And we feel very lucky….
0
2
0